kyvero
Market leaders

FTRE

Fortrea Holdings Inc. (FTRE)

Healthcare • Biotechnology

StockNasdaqGSUnited StatesUS34965K1079

20.08 USD -1.47% today Updated 12 Nov 2026 20:50

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Fortrea Holdings Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 12 Nov 2026 20:50. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 25 Feb 2027 in 104 days · 08:00 · estimate 0.19
Last results 0.28 vs 0.22 estimated 29 Oct 2026 · Beat +28.9%
Beat the estimate 5 of 12 7 missed · 0 in line · 3 beats in a row
Average surprise -93.7% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

11 Mar 2024: estimate 0.23 11 Mar 2024: reported 0.19 03/24 13 May 2024: reported -0.04 05/24 12 Aug 2024: estimate 0.06 12 Aug 2024: reported -0.03 08/24 08 Nov 2024: estimate 0.25 08 Nov 2024: reported 0.23 11/24 03 Mar 2025: estimate 0.37 03 Mar 2025: reported 0.18 03/25 12 May 2025: estimate -0.07 12 May 2025: reported 0.02 05/25 06 Aug 2025: estimate 0.08 06 Aug 2025: reported 0.19 08/25 05 Nov 2025: estimate 0.16 05 Nov 2025: reported 0.12 11/25 26 Feb 2026: estimate 0.16 26 Feb 2026: reported 0.09 02/26 05 May 2026: estimate 0.05 05 May 2026: reported 0.16 05/26 29 Jul 2026: estimate 0.18 29 Jul 2026: reported 0.23 07/26 29 Oct 2026: estimate 0.22 29 Oct 2026: reported 0.28 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
25 Feb 2027 08:00 0.19 — — Upcoming
29 Oct 2026 06:00 0.22 0.28 +28.9% Beat
29 Jul 2026 06:00 0.18 0.23 +27.2% Beat
05 May 2026 06:00 0.05 0.16 +211.9% Beat
26 Feb 2026 06:00 0.16 0.09 -43.8% Miss
05 Nov 2025 06:00 0.16 0.12 -25.7% Miss
06 Aug 2025 06:00 0.08 0.19 +152.5% Beat
12 May 2025 06:00 -0.07 0.02 +130.3% Beat
03 Mar 2025 06:00 0.37 0.18 -50.7% Miss
08 Nov 2024 06:00 0.25 0.23 -8.3% Miss
12 Aug 2024 07:00 0.06 -0.03 -146.9% Miss
13 May 2024 06:00 — -0.04 -1,382.1% Miss
11 Mar 2024 06:00 0.23 0.19 -17.9% Miss
13 Nov 2023 06:00 0.16 0.24 +49.5% Beat
14 Aug 2023 07:00 0.39 0.52 +33.3% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 2.7B +1.0% -986.2M -36.2% -10.81 -194.6% 88.3M
2024 2.7B -5.1% -328.5M -12.2% -3.67 -9,075.0% 237.3M
2023 2.8B +0.2% -25.2M -0.9% -0.04 -101.9% 128.1M
2022 2.8B — 186.2M 6.6% 2.11 — 28.3M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
12 Nov 2026 19.85 20.29 18.97 20.08 -1.47% 1,108,538
11 Nov 2026 20.94 21.58 20.36 20.38 -4.72% 1,518,200
10 Nov 2026 22.01 22.04 20.86 21.39 -3.82% 1,335,300
09 Nov 2026 22.60 23.04 22.15 22.24 +1.28% 1,361,900
06 Nov 2026 20.46 22.12 20.14 21.96 +7.33% 1,941,800
05 Nov 2026 20.53 20.80 19.89 20.46 -1.78% 2,399,800
04 Nov 2026 21.42 21.84 20.15 20.83 -0.57% 1,434,900
03 Nov 2026 19.93 21.33 19.66 20.95 +4.65% 1,578,200
02 Nov 2026 21.41 21.56 19.75 20.02 -5.97% 1,752,200
30 Oct 2026 23.30 23.51 20.70 21.29 -7.97% 2,873,500
846 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
20.38 USD
Market cap
1.9B
Exchange
NasdaqGS
Country
United States
Sector
Healthcare
Industry
Biotechnology
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 0.0 / 25
  • Revenue growth of -1.4% a year
Quality Return on equity, net margin and how stable the margins are. 0.0 / 25
  • ROE of -12%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 6.7 / 20
  • Net debt is 7.6× EBITDA
  • Free cash flow yield of 13.0%
Valuation Free cash flow yield and the P/E against its sector. 13.4 / 15
  • Forward P/E 18.0: it is expected to earn money
Analysts How far the analysts' average target is from today's price. 9.2 / 10
  • Analysts' target is +18% from the price
  • Score capped at 50: three or more warnings
  • Heavy debt: net debt is 7.6× EBITDA
  • Thin interest cover: operating profit is only -0.3× the interest
  • The last full year was a loss

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 18 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (forward) 17.99× Fair 14.16×
Price / book 3.64× Weak 3.5×
Price / sales 0.73× Good 3.33×
EV / EBITDA 24.26× Weak 11.19×
Free cash flow yield 13% Good 2.1%
Quality
FigureValueReading Sector median
Gross margin 20% Fair 54.9%
Operating margin 1.7% Weak 5.8%
Net margin -2.6% Weak 1.2%
Return on equity -12.3% Weak 4.4%
Return on assets 1% Weak 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year -1.4% Weak 10.1%
Financial health
FigureValueReading Sector median
Debt / equity 2.1× Weak 0.4×
Net debt / EBITDA 7.6× Weak 1.46×
Interest cover -0.33× Weak 2.17×
Current ratio 0.97× Weak 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow FTRE and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in